The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
Sportschosun on MSN1d
Development of a precise prediction model for prognosis and survival rate of colorectal cancer liver metastasis patients with AIKorean researchers have developed an artificial intelligence (AI) model that can accurately predict the prognosis and ...
Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...
Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...
Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action SEATTLE, WASHINGTON / ACCESS Newswire / March 18, 2025 / Aptevo Therapeutics (NASDAQ:APVO), a ...
Aptevo Therapeutics (APVO) provided an overview of solid tumor anti-cancer compound APVO603, currently in preclinical development for the ...
Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy ...
Altis's AI Model Outperforms RECIST 1.1 in Predicting Overall Survival These findings showcase IPRO-Δ's potential to accelerate clinical d ...
RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
News-Medical.Net on MSN7d
Researchers develop tool to enhance NK cells against cancerA team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback